GWPHARM Trademark

Trademark Overview


On Thursday, June 5, 2014, a trademark application was filed for GWPHARM with the United States Patent and Trademark Office. The USPTO has given the GWPHARM trademark a serial number of 79154002. The federal status of this trademark filing is IR CANCELLED - US APPLICATION ABANDONED as of Thursday, June 6, 2024. This trademark is owned by GW Pharma Limited. The GWPHARM trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of pain, neuropathic pain, cancer pain, perioperative pain, oncology, cancer symptoms, multiple sclerosis, spasticity, convulsions, seizures, epilepsy, paediatric epilepsy, intractable childhood epilepsy with generalized tonic-clonic seizures (ICE-GTC), generalized epilepsy with febrile seizures plus (GEFS+), dup 15, Doose syndrome, bladder dysfunction, inflammatory bowel disease, ulcerative colitis, Crohn's disease, Alzheimer's, Dravet syndrome, Lennox-Gastaut syndrome (LGS), spinal cord injury, head injury, bone disorders, chromosome disorders, inflammatory disorders, inflammation, arthritis, metabolic disorders, oncology, cancer symptoms, neurodegenerative diseases, diseases of the central nervous system, peripheral neuropathy, neurogenic symptoms, hypoxic-ischemic encephalopathy, stroke, motion sickness, chemically induced sickness, diabetes, obesity, obesity associated with diabetes, bulimia, psychiatric disorders, schiz...

General Information


Serial Number79154002
Word MarkGWPHARM
Filing DateThursday, June 5, 2014
Status402 - IR CANCELLED - US APPLICATION ABANDONED
Status DateThursday, June 6, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 17, 2015

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for the treatment of pain, neuropathic pain, cancer pain, perioperative pain, oncology, cancer symptoms, multiple sclerosis, spasticity, convulsions, seizures, epilepsy, paediatric epilepsy, intractable childhood epilepsy with generalized tonic-clonic seizures (ICE-GTC), generalized epilepsy with febrile seizures plus (GEFS+), dup 15, Doose syndrome, bladder dysfunction, inflammatory bowel disease, ulcerative colitis, Crohn's disease, Alzheimer's, Dravet syndrome, Lennox-Gastaut syndrome (LGS), spinal cord injury, head injury, bone disorders, chromosome disorders, inflammatory disorders, inflammation, arthritis, metabolic disorders, oncology, cancer symptoms, neurodegenerative diseases, diseases of the central nervous system, peripheral neuropathy, neurogenic symptoms, hypoxic-ischemic encephalopathy, stroke, motion sickness, chemically induced sickness, diabetes, obesity, obesity associated with diabetes, bulimia, psychiatric disorders, schizophrenia, and drug, alcohol and nicotine abuse; veterinary preparations and substances for the treatment of pain, neuropathic pain, cancer pain, perioperative pain, oncology, cancer symptoms, spasticity, convulsions, seizures, epilepsy, bladder dysfunction, inflammatory bowel disease, ulcerative colitis, spinal cord injury, head injury, bone disorders, chromosome disorders, inflammatory disorders, inflammation, arthritis, metabolic disorders, oncology, cancer symptoms, neurodegenerative diseases, diseases of the central nervous system, peripheral neuropathy, neurogenic symptoms, Hypoxic-ischemic encephalopathy, stroke, motion sickness and chemically induced sickness, diabetes, obesity, obesity associated with diabetes; herbs for medicinal purposes; medicinal herbs; medicinal oils; medicinal infusions for treating pain, neuropathic pain, cancer pain, perioperative-operative pain, oncology, cancer symptoms, multiple sclerosis, spasticity, convulsions, seizures, epilepsy, paediatric epilepsy, intractable childhood epilepsy with generalized tonic-clonic seizures (ICE-GTC), generalized epilepsy with febrile seizures plus (GEFS+), dup 15, Doose syndrome, bladder disfunction, inflammatory bowel disease, ulcerative colitis, Crohn's disease, Alzheimer's, Dravet syndrome, Lennox-Gastaut syndrome (LGS), spinal cord injury, head injury, bone disorders, chromosome disorders, inflammatory disorders, inflammation, arthritis, metabolic disorders, oncology, cancer symptoms, neurodegenerative diseases, diseases of the central nervous system, peripheral neuropathy, neurogenic symptoms, Hypoxic-ischemic encephalopathy, stroke, motion sickness, chemically induced sickness, diabetes, obesity, obesity associated with diabetes, bulimia, psychiatric disorders, schizophrenia, and drug, alcohol and nicotine abuse; pure extracts of medicinal plants and herbs for medical, veterinary and pharmaceutical purposes; foodstuffs for medicinal purposes, namely, medicated supplements for foodstuffs for babies and animals; herb teas for medicinal purposes
Pseudo MarkGW PHARMACEUTICALS

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code8 - Abandoned
Class Status DateTuesday, October 13, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGW Pharma Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressGB

Party NameGW Pharma Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressSalisbury; Wiltshire SP4 OJR
GB

Trademark Events


Event DateEvent Description
Thursday, October 30, 2014SN ASSIGNED FOR SECT 66A APPL FROM IB
Tuesday, November 4, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, November 4, 2014ASSIGNED TO EXAMINER
Tuesday, November 4, 2014NON-FINAL ACTION WRITTEN
Wednesday, November 5, 2014NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, November 6, 2014REFUSAL PROCESSED BY MPU
Thursday, November 6, 2014NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, November 8, 2014APPLICATION FILING RECEIPT MAILED
Friday, November 21, 2014REFUSAL PROCESSED BY IB
Saturday, November 22, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, November 22, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, November 22, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, November 25, 2014TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, November 25, 2014ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sunday, December 21, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, January 12, 2015ASSIGNED TO LIE
Monday, January 12, 2015ASSIGNED TO LIE
Wednesday, January 14, 2015ASSIGNED TO LIE
Wednesday, January 14, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, January 28, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, January 28, 2015NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, January 28, 2015NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Saturday, February 14, 2015NOTIFICATION PROCESSED BY IB
Tuesday, February 17, 2015PUBLISHED FOR OPPOSITION
Tuesday, February 17, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, March 19, 2015OPPOSITION PAPERS RECEIVED AT TTAB
Friday, March 20, 2015OPPOSITION NOTICE (IB REFUSAL) CREATED
Friday, March 20, 2015OPPOSITION NOTICE (IB REFUSAL) SENT TO IB
Monday, March 23, 2015OPPOSITION INSTITUTED NO. 999999
Friday, April 24, 2015REFUSAL PROCESSED BY IB
Friday, June 19, 2015CHANGE OF NAME/ADDRESS REC'D FROM IB
Tuesday, October 13, 2015OPPOSITION TERMINATED NO. 999999
Tuesday, October 13, 2015OPPOSITION SUSTAINED NO. 999999
Tuesday, October 13, 2015ABANDONMENT - AFTER INTER PARTES DECISION
Tuesday, October 13, 2015ABANDONMENT NOTICE MAILED - INTER PARTES DECISION
Thursday, October 13, 2016FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Thursday, October 13, 2016FINAL DISPOSITION NOTICE SENT TO IB
Friday, October 28, 2016FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, December 21, 2017NEW REPRESENTATIVE AT IB RECEIVED
Saturday, November 20, 2021NEW REPRESENTATIVE AT IB RECEIVED
Saturday, December 21, 2024DEATH OF INTERNATIONAL REGISTRATION
Saturday, December 21, 2024NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED